- * Any patient receiving CSL Behring's C1-esterase inhibitor
- * Written informed consent (may not be required for some retrospective chart review cases)
Includes: Hereditary Angioedema
Patient Registry Study of Berinert® in Normal Clinical Practice
NCT01108848 | PHASE 3 | OBSERVATIONAL
The objective of this patient registry is to collect data on the safety of Berinert® in normal clinical practice in the United States. The patient registry will be maintained for a period of at least 3 years. The duration of individual patient participation will vary and is determined by the frequency of hereditary angioedema (HAE) attacks and the patient's need for Berinert® treatment.
Trial Information
If interested, contact clinicaltrials@cslbehring.com for more information
CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy
United States, Arizona
Scottsdale,Arizona,United States,85251
United States, California
Granada Hills,California,United States,91344
United States, California
Los Angeles,California,United States,90095
United States, California
Redding,California,United States,96003
United States, California
San Diego,California,United States,92093
United States, Georgia
Atlanta,Georgia,United States,30342
United States, Idaho
Idaho Falls,Idaho,United States,83404
United States, Louisiana
New Orleans,Louisiana,United States,70118
United States, Maryland
Chevy Chase,Maryland,United States,20815
United States, Maryland
Columbia,Maryland,United States,21044
United States, Massachusetts
Boston,Massachusetts,United States,02115
United States, Minnesota
Plymouth,Minnesota,United States,55446
United States, Missouri
Kansas City,Missouri,United States,64108
United States, Missouri
St. Louis,Missouri,United States,63110
United States, New Jersey
Branchburg,New Jersey,United States,08876
United States, New Jersey
Edison,New Jersey,United States,88220
United States, New Jersey
Iselin,New Jersey,United States,08830
United States, New Jersey
Ocean,New Jersey,United States,07712
United States, New York
New York,New York,United States,10029
United States, New York
North Syracuse,New York,United States,13212
United States, North Carolina
Durham,North Carolina,United States,27710
United States, Ohio
Centerville,Ohio,United States,45458
United States, Ohio
Cincinnati,Ohio,United States,45267
United States, Oklahoma
Oklahoma City,Oklahoma,United States,73131
United States, Oklahoma
Tulsa,Oklahoma,United States,74133
United States, Oregon
Lake Oswego,Oregon,United States,97035
United States, Pennsylvania
Altoona,Pennsylvania,United States,16601
United States, Pennsylvania
Hershey,Pennsylvania,United States,17033
United States, Pennsylvania
Pittsburgh,Pennsylvania,United States,15213
United States, South Carolina
Columbia,South Carolina,United States,29203
United States, South Dakota
Rapid City,South Dakota,United States,57702
United States, Texas
Dallas,Texas,United States,75231
United States, Washington
Spokane,Washington,United States,99204
United States, Washington
Tacoma,Washington,United States,98405
Denmark, Odense C
Odense C,Denmark,5000
Germany, Berlin
Berlin,Germany,10117
Germany, Frankfurt
Frankfurt,Germany,60596
Germany, Mainz
Mainz,Germany,55101
Germany, Mnchen
München,Germany,81675
Switzerland, Luzern
Luzern 16,Switzerland,CH-6000
Study Eligibility Criteria
Additional Studies
Additional studies can be found at ClinicalTrials.gov